Nebula Research & Development LLC Applied Therapeutics Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$5.87 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$5.1 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$4.9 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$4.5 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$4.47 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $24.5M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...